Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NTRA - Natera Inc


IEX Last Trade
118.215
1.965   1.662%

Share volume: 870,648
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$116.25
1.97
1.69%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 25%
Dept financing 14%
Liquidity 67%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-3.63%
1 Month
20.98%
3 Months
7.39%
6 Months
54.49%
1 Year
100.10%
2 Year
148.86%
Key data
Stock price
$118.22
P/E Ratio 
-50.07
DAY RANGE
N/A - N/A
EPS 
-$2.44
52 WEEK RANGE
$36.90 - $124.83
52 WEEK CHANGE
$0.89
MARKET CAP 
14.627 B
YIELD 
N/A
SHARES OUTSTANDING 
123.681 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
1.46
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,206,958
AVERAGE 30 VOLUME 
$1,409,306
Company detail
CEO:
Region: US
Website: natera.com
Employees: 3,122
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the

Recent news